SCHEMBL14444419

SCHEMBL14444419

Bc1cccc(/C=C2/C(=O)NN(c3ccc(C(=O)OCC)cc3)C2=O)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 9/20 0.61
▸ MEN1 O00255 6/20 0.61
▸ POLB P06746 3/20 0.61
▸ ALDH1A1 P00352 3/20 0.61
▸ MAPT P10636 3/20 0.61
▸ HPGD P15428 2/20 0.61
▸ NPSR1 Q6W5P4 2/20 0.61
▸ LMNA P02545 2/20 0.61
▸ GAA P10253 7/20 0.53
▸ PSMD14 O00487 1/20 0.53
▸ MMP2 P08253 1/20 0.53
▸ NR1H4 Q96RI1 2/20 0.48
▸ ARHGEF12 Q9NZN5 1/20 0.48
▸ CDC25B P30305 1/20 0.47
▸ PKM P14618 1/20 0.47
▸ ALOX12 P18054 1/20 0.47
▸ TDP1 Q9NUW8 1/20 0.47
▸ ABL1 P00519 1/20 0.46
▸ SRC P12931 1/20 0.46
▸ DYRK1A Q13627 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13056449 0.89 KMT2A (0.60) KMT2AMEN1POLBALDH1A1MAPT
SCHEMBL5454202 0.88 KMT2A (0.62) KMT2AMEN1POLBALDH1A1MAPT
SCHEMBL5454199 0.88 KMT2A (0.62) KMT2AMEN1POLBALDH1A1MAPT
SCHEMBL5444388 0.88 GAA (0.68) KMT2AMEN1POLBALDH1A1MAPT
SCHEMBL5444385 0.88 GAA (0.68) KMT2AMEN1POLBALDH1A1MAPT
SCHEMBL14444650 0.87 KMT2A (0.58) KMT2AMEN1POLBALDH1A1MAPT
SCHEMBL12632696 0.87 KMT2A (0.58) KMT2AMEN1POLBALDH1A1MAPT
SCHEMBL14304685 0.85 KMT2A (0.57) KMT2AMEN1POLBALDH1A1MAPT
SCHEMBL14270436 0.85 KMT2A (0.57) KMT2AMEN1POLBALDH1A1MAPT
SCHEMBL5442095 0.83 KMT2A (0.58) KMT2AMEN1POLBALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070203236-A1 NOVEL ANTAGONISTS OF THE HUMAN FATTY ACID SYNTHASE THIOESTERASE UNITED STATES GOVERNMENT 2007-08-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070203236-A1 NOVEL ANTAGONISTS OF THE HUMAN FATTY ACID SYNTHASE THIOESTERASE FADS2, ACOT7, FADS1 KMT2A 3767/4885MEN1 3665/4885POLB 3681/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback